Losartan

In the reduction of stroke risk in patients with hypertension and left ventricular hypertrophy: Viewpoints

Sverre E. Kjeldsen, Jorge Kizer

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)378-379
Number of pages2
JournalAmerican Journal of Cardiovascular Drugs
Volume3
Issue number5
StatePublished - 2003
Externally publishedYes

Fingerprint

Losartan
Left Ventricular Hypertrophy
Risk Reduction Behavior
Stroke
Hypertension

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

@article{9d5cded586904188919aab1177a277ed,
title = "Losartan: In the reduction of stroke risk in patients with hypertension and left ventricular hypertrophy: Viewpoints",
author = "Kjeldsen, {Sverre E.} and Jorge Kizer",
year = "2003",
language = "English (US)",
volume = "3",
pages = "378--379",
journal = "American Journal of Cardiovascular Drugs",
issn = "1175-3277",
publisher = "Adis International Ltd",
number = "5",

}

TY - JOUR

T1 - Losartan

T2 - In the reduction of stroke risk in patients with hypertension and left ventricular hypertrophy: Viewpoints

AU - Kjeldsen, Sverre E.

AU - Kizer, Jorge

PY - 2003

Y1 - 2003

UR - http://www.scopus.com/inward/record.url?scp=0242636297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242636297&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 378

EP - 379

JO - American Journal of Cardiovascular Drugs

JF - American Journal of Cardiovascular Drugs

SN - 1175-3277

IS - 5

ER -